STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Clinical trials for STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo offers hope for head and neck cancer patients who Can't take chemo
Disease control OngoingThis early-stage trial tests a drug called peposertib combined with radiation therapy for people with advanced head and neck cancer who cannot take the standard chemo drug cisplatin. The study aims to find the safest dose of peposertib and see if the combination helps control the…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:42 UTC
-
New combo shows promise against tough head and neck cancers
Disease control OngoingThis study tests a combination of an immunotherapy drug (cemiplimab) and two low-dose chemotherapy drugs (paclitaxel and carboplatin) in people whose head and neck cancer has returned or spread. The goal is to see if this mix can shrink tumors better than standard treatments. Abo…
Matched conditions: STAGE IVA LIP AND ORAL CAVITY CANCER AJCC V8
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated May 01, 2026 15:41 UTC